Breaking News Instant updates and real-time market news.

BA

Boeing

$196.44

0.99 (0.51%)

, GE

General Electric

$29.00

0.06 (0.21%)

08:52
06/19/17
06/19
08:52
06/19/17
08:52

Aviall named preferred parts, engine provider for CFM56-7B powered Boeing jets

Boeing (BA) announced, through its subsidiary Aviall, an agreement with GE Aviation (GE) to become the preferred provider of CFM56-7B parts and engines for Boeing Business Jets. The agreement supports GE Aviation's OnPoint service program for CFM56 engines and includes support of new and used parts, lease engines and line-replaceable units for engines installed on Boeing Business Jets.

BA

Boeing

$196.44

0.99 (0.51%)

GE

General Electric

$29.00

0.06 (0.21%)

  • 20

    Jun

  • 22

    Jun

  • 02

    Oct

BA Boeing
$196.44

0.99 (0.51%)

05/09/17
UBSW
05/09/17
UPGRADE
Target $63
UBSW
Buy
Spirit AeroSystems upgraded to Buy from Neutral at UBS
UBS analyst David Strauss upgraded Spirit AeroSystems to Buy citing a favorable risk/reward following the recent pullback in the shares. The selloff reflects concerns around Spirit's pricing negotiations with Boeing (BA), Strauss tells investors in a research note. The analyst believes current share levels reflect a 35% decline in legacy 737/777 cash, which is well below his forecast. He his price target for Spirit AeroSystems remains $63.
05/10/17
COWN
05/10/17
NO CHANGE
COWN
Boeing 737 MAX engine issue likely very short-term and correctable, says Cowen
Cowen said the Boeing 737 MAX engine issue appears to be a very short-term "blip" and correctable. The firm's analyst doesn't think its a serious concern because Boeing still expects to deliver the first 737 MAX this month and the engine "problem" is not a design shortfall but what appears to be an easily fixable sub-tier supplier component problem.
05/22/17
LEHM
05/22/17
NO CHANGE
Target $200
LEHM
Overweight
Boeing price target raised to $200 from $190 at Barclays
Barclays analyst Carter Copeland raised his price target for Boeing to $200 saying the company "possesses significant margin expansion potential" in the coming years. Investors are unwilling to believe in Boeing's margin expansion potential, Copeland tells investors in a research note. He keeps an Overweight rating on the shares.
06/05/17
SBSH
06/05/17
NO CHANGE
Target $70
SBSH
Buy
Citi sees path for Spirit AeroSystems hitting $85/share
Spirit AeroSystems (SPR) is trading near its all-time deepest earnings discount versus Boeing (BA) despite Spirit generating better financial results, Citi analyst Jason Gursky tells investors in a research note. While the protracted Boeing negotiation is an overhang, it is already reflected in the multiple, the analyst argues. He highlights Spirit's improving cash flow, balance sheet flexibility, shareholder-friendly cash deployment and new growth opportunities. He sees a path to $85 per share "over time" and reiterates a Buy rating on the shares with a one-year target of $70.
GE General Electric
$29.00

0.06 (0.21%)

05/25/17
DBAB
05/25/17
NO CHANGE
Target $24
DBAB
Sell
GE officially walked away from 2018 EPS target, says Deutsche Bank
Deutsche Bank analyst John Inch says General Electric CEO Jeff Immelt at a conference yesterday officially walked away from the company's $2.00-plus earnings per share framework for 2018 citing tougher markets. While investors had expected GE to abandon the $2.00-plus target, the company kept $2.00 per share at the high end of its 2018 framework, Inch tells investors in a research note. He believes $2.00 to be unrealistic, even as just a high point in the range. The analyst sees cash flow pressures continuing in 2018 and keeps a Sell rating on GE with a $24 price target.
05/31/17
DBAB
05/31/17
NO CHANGE
Target $24
DBAB
Sell
General Electric setting stage for dividend cut, says Deutsche Bank
Deutsche Bank analyst John Inch believes the stage is being set for General Electric to cut its common dividend. The analyst has a Sell rating on the shares with a $24 price target. Last Wednesday at a conference, GE provided a cash flow walk for the next two years that suggests it is likely to generate insufficient free cash flow to cover its common dividend this year, and barely enough next year, Inch tells investors in a research note. He believes a "reasonable dividend payout" on a future earnings reset could result in a GE dividend cut to 65c-75c. A dividend reduction could be part of an earnings "reset" lower and possibly in conjunction with eventual future leadership change, Inch writes.
06/01/17
FBCO
06/01/17
NO CHANGE
Target $34
FBCO
Outperform
General Electric has reached attractive entry point, says Credit Suisse
Credit Suisse analyst Julian Mitchell thinks the pendulum of investor sentiment regarding General Electric has swung too far in the negative direction, creating an attractive entry point into the stock. GE's organic growth seems underappreciated, argues Mitchell, who notes that its organic sales growth has topped most Electrical Equipment and Multi-Industry peers in recent years and into 2017. Meanwhile, GE's segments have shown "fairly healthy" operating leverage, added Mitchell, who has an Outperform rating and $34 price target on GE shares.
06/13/17
STFL
06/13/17
NO CHANGE
STFL
New General Electric CEO likely pleases investors, says Stifel
Stifel analyst Robert McCarthy says that investors were probably more pleased with GE's new CEO, John Flannery, than they would have been with either of the other two candidates- GE Power CEO Steve Bolze and CFO Jeff Bornstein. Flannery is viewed as more willing to make major changes than Bolze and is seen as not being as tied to the outgoing CEO as Bornstein, according to McCarthy. The analyst reiterates a $33 price target and a Buy rating on the stock.

TODAY'S FREE FLY STORIES

MDGL

Madrigal Pharmaceuticals

$19.80

0.99 (5.26%)

07:41
09/19/17
09/19
07:41
09/19/17
07:41
Hot Stocks
Madrigal Pharmaceuticals announces positive outcome from pre-planned DSMB review »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MDSO

Medidata

$75.85

-0.01 (-0.01%)

07:40
09/19/17
09/19
07:40
09/19/17
07:40
Initiation
Medidata initiated  »

Medidata initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

ABX

Barrick Gold

$16.92

-0.38 (-2.20%)

07:40
09/19/17
09/19
07:40
09/19/17
07:40
Conference/Events
Barrick Gold management to meet with Deutsche Bank »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 26

    Oct

07:40
09/19/17
09/19
07:40
09/19/17
07:40
General news
Treasury Market Outlook: yields are a little lower »

Treasury Market Outlook:…

SFTBF

SoftBank

$78.30

0.3501 (0.45%)

07:39
09/19/17
09/19
07:39
09/19/17
07:39
Periodicals
SoftBank Ventures Korea looks to invest in promising start-ups, CNBC says »

SoftBank Ventures Korea,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCK

McKesson

$148.42

-1.46 (-0.97%)

07:38
09/19/17
09/19
07:38
09/19/17
07:38
Initiation
McKesson initiated  »

McKesson initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 27

    Sep

SUPN

Supernus

$49.65

0.6 (1.22%)

07:37
09/19/17
09/19
07:37
09/19/17
07:37
Downgrade
Supernus rating change  »

Supernus downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

HSIC

Henry Schein

$80.90

-1.98 (-2.39%)

07:37
09/19/17
09/19
07:37
09/19/17
07:37
Initiation
Henry Schein initiated  »

Henry Schein initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMX

CarMax

$68.34

0.26 (0.38%)

07:36
09/19/17
09/19
07:36
09/19/17
07:36
Recommendations
CarMax analyst commentary  »

CarMax price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

PTLA

Portola Pharmaceuticals

$56.57

1.62 (2.95%)

07:36
09/19/17
09/19
07:36
09/19/17
07:36
Periodicals
Portola blood thinner launch could be complicated by guidelines, STAT News says »

The commercial launch of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

CRL

Charles River

$107.29

1.27 (1.20%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Initiation
Charles River initiated  »

Charles River initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POST

Post Holdings

$85.84

1.04 (1.23%)

, BOBE

Bob Evans

$72.93

1.02 (1.42%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Hot Stocks
Post Holdings to acquire Bob Evans for $77.00 per share »

Post Holdings (POST) and…

POST

Post Holdings

$85.84

1.04 (1.23%)

BOBE

Bob Evans

$72.93

1.02 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$170.01

-1.63 (-0.95%)

, AMZN

Amazon.com

$974.19

-12.6 (-1.28%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Periodicals
FB design head touts voice command, stays silent on hardware, TechCrunch says »

Facebook (FB) head of…

FB

Facebook

$170.01

-1.63 (-0.95%)

AMZN

Amazon.com

$974.19

-12.6 (-1.28%)

GOOG

Alphabet

$915.00

-5.29 (-0.57%)

GOOGL

Alphabet Class A

$929.75

-5.54 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

OA

Orbital ATK

$132.25

22.21 (20.18%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Downgrade
Orbital ATK rating change  »

Orbital ATK downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$187.55

7.44 (4.13%)

, FCX

Freeport McMoRan

$14.13

0.25 (1.80%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

NVDA

Nvidia

$187.55

7.44 (4.13%)

FCX

Freeport McMoRan

$14.13

0.25 (1.80%)

WFC

Wells Fargo

$52.71

1.05 (2.03%)

V

Visa

$104.83

-0.47 (-0.45%)

HIMX

Himax

$10.70

0.15 (1.42%)

COP

ConocoPhillips

$47.09

0.58 (1.25%)

STX

Seagate

$33.52

-0.03 (-0.09%)

MOS

Mosaic

$21.31

0.65 (3.15%)

TMUS

T-Mobile

$61.80

0.63 (1.03%)

FCAU

Fiat Chrysler

$16.82

0.16 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

  • 12

    Oct

  • 29

    Nov

  • 15

    Jan

ESRX

Express Scripts

$62.01

-0.64 (-1.02%)

, ANTM

Anthem

$185.00

-1.59 (-0.85%)

07:34
09/19/17
09/19
07:34
09/19/17
07:34
Initiation
Express Scripts, Anthem initiated  »

Express Scripts initiated…

ESRX

Express Scripts

$62.01

-0.64 (-1.02%)

ANTM

Anthem

$185.00

-1.59 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 25

    Oct

WBS

Webster Financial

$48.71

0.73 (1.52%)

07:33
09/19/17
09/19
07:33
09/19/17
07:33
Hot Stocks
Webster Financial announces CEO succession »

Webster Financial's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

AAPL

Apple

$158.67

-1.21 (-0.76%)

07:32
09/19/17
09/19
07:32
09/19/17
07:32
Recommendations
Apple analyst commentary  »

Apple price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$16.99

-1.11 (-6.13%)

07:32
09/19/17
09/19
07:32
09/19/17
07:32
Hot Stocks
Teva completes amendment to credit facilities »

Teva Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

CTLT

Catalent

$39.90

0.41 (1.04%)

07:31
09/19/17
09/19
07:31
09/19/17
07:31
Hot Stocks
Catalent to acquire Cook Pharmica for $950M »

Catalent announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRTX

Mirati Therapeutics

$10.80

-0.4 (-3.57%)

07:31
09/19/17
09/19
07:31
09/19/17
07:31
Initiation
Mirati Therapeutics initiated  »

Mirati Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

POST

Post Holdings

$85.84

1.04 (1.23%)

, BOBE

Bob Evans

$72.93

1.02 (1.42%)

07:31
09/19/17
09/19
07:31
09/19/17
07:31
Hot Stocks
Breaking Hot Stocks news story on Post Holdings, Bob Evans »

Post Holdings to acquire…

POST

Post Holdings

$85.84

1.04 (1.23%)

BOBE

Bob Evans

$72.93

1.02 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITRI

Itron

$76.50

3.7 (5.08%)

, SSNI

Silver Spring

$16.10

3.1 (23.85%)

07:30
09/19/17
09/19
07:30
09/19/17
07:30
Downgrade
Itron, Silver Spring rating change  »

Itron downgraded to Hold…

ITRI

Itron

$76.50

3.7 (5.08%)

SSNI

Silver Spring

$16.10

3.1 (23.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOBE

Bob Evans

$72.93

1.02 (1.42%)

07:30
09/19/17
09/19
07:30
09/19/17
07:30
Hot Stocks
Breaking Hot Stocks news story on Bob Evans »

Bob Evans trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.42

0.32 (0.86%)

, CRM

Salesforce

$95.74

1.11 (1.17%)

07:30
09/19/17
09/19
07:30
09/19/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

T

AT&T

$37.42

0.32 (0.86%)

CRM

Salesforce

$95.74

1.11 (1.17%)

AXON

Axovant Sciences

$22.88

1.54 (7.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 29

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.